概日時計駆動の腫瘍免疫調節:メカニズムの洞察と治療における新たな展望
Yuye Feng1, Qiyang Li2, Yutong Wang1
1Provincial-Level Key Laboratory for Molecular Medicine of Major Diseases and the Prevention and Treatment with Traditional Chinese Medicine Research in Gansu Colleges and Universities, Gansu University of Chinese Medicine, Lanzhou, China.
Abstract:
Immunotherapy has emerged as a cornerstone of modern oncology; however, its clinical efficacy is frequently constrained by adaptive resistance mechanisms. The circadian clock, a fundamental regulator of metabolism and immunity, governs immune surveillance and tumor microenvironment (TME) dynamics through transcription-translation feedback loops (TTFLs). Disruption of these rhythms-Manifested as clock gene dysregulation, central-peripheral desynchrony, and aberrant metabolic-inflammatory signaling-Creates a permissive environment for tumor immune evasion. Although circadian-targeted therapies show promise, the mechanisms linking circadian disruption to immune escape remain incompletely understood, and the potential of natural products and traditional Chinese medicine (TCM) to modulate these rhythms lacks systematic evaluation. This review critically examines the multilayered mechanisms by which circadian disruption drives immune evasion, specifically targeting the breakdown of immune checkpoint balance and the metabolic-inflammation axis. We further synthesize recent advances in circadian-modulating agents, including natural compounds, and specifically evaluate the alignment between their pharmacokinetic profiles and biological rhythm windows. Finally, we propose an "integrative chrono-immunotherapy" strategy, combining TCM wisdom with emerging technologies such as nanotechnology and multi-omics, to provide a theoretical framework for next-generation precision cancer treatments.
関連する概念動画
Tumor Immunotherapy
The Tumor Microenvironment
Circadian Rhythms and Gene Regulation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Targeted Cancer Therapies
There are several types of targeted therapies against...


